123 related articles for article (PubMed ID: 8157205)
1. Expression of human sialophorin (CD43) in a human x mouse somatic cell hybrid.
Ramadan HA; Monostori E; Cserpan I; Ocsovszky I; Andó I
Haematologia (Budap); 1993; 25(4):237-47. PubMed ID: 8157205
[TBL] [Abstract][Full Text] [Related]
2. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line.
Lefebvre JC; Giordanengo V; Limouse M; Doglio A; Cucchiarini M; Monpoux F; Mariani R; Peyron JF
J Exp Med; 1994 Nov; 180(5):1609-17. PubMed ID: 7964449
[TBL] [Abstract][Full Text] [Related]
3. Concentration of an integral membrane protein, CD43 (leukosialin, sialophorin), in the cleavage furrow through the interaction of its cytoplasmic domain with actin-based cytoskeletons.
Yonemura S; Nagafuchi A; Sato N; Tsukita S
J Cell Biol; 1993 Jan; 120(2):437-49. PubMed ID: 8421057
[TBL] [Abstract][Full Text] [Related]
4. CD43 (leukosialin, sialophorin, large sialoglycoprotein) can be expressed in both normal and Wiskott-Aldrich fibroblasts via transfection of a leukosialin cDNA.
Pallant A; Fukuda M; Frelinger JG
Eur J Immunol; 1990 Jul; 20(7):1423-8. PubMed ID: 2143724
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to leucosialin (CD43) induce homotypic aggregation of the human mast cell line HMC-1: characterization of leucosialin on HMC-1 cells.
Weber S; Ruh B; Dippel E; Czarnetzki BM
Immunology; 1994 Aug; 82(4):638-44. PubMed ID: 7835929
[TBL] [Abstract][Full Text] [Related]
6. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1.
Rosenstein Y; Park JK; Hahn WC; Rosen FS; Bierer BE; Burakoff SJ
Nature; 1991 Nov; 354(6350):233-5. PubMed ID: 1683685
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a 95 kDa human leucocyte sialoglycoprotein: its identity with CD43, gpL115, leukosialin and sialophorin.
Stefanová I; Hilgert I; Angelisová P; Kristofová H; Horejsí V
Folia Biol (Praha); 1988; 34(4):255-65. PubMed ID: 2467832
[TBL] [Abstract][Full Text] [Related]
8. Expression of the leukocyte-associated sialoglycoprotein CD43 by a colon carcinoma cell line.
Baeckström D; Zhang K; Asker N; Rüetschi U; Ek M; Hansson GC
J Biol Chem; 1995 Jun; 270(23):13688-92. PubMed ID: 7775421
[TBL] [Abstract][Full Text] [Related]
9. Sialophorin (CD43) and the Wiskott-Aldrich syndrome.
Remold-O'Donnell E; Rosen FS
Immunodefic Rev; 1990; 2(2):151-74. PubMed ID: 2223062
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome.
Park JK; Rosenstein YJ; Remold-O'Donnell E; Bierer BE; Rosen FS; Burakoff SJ
Nature; 1991 Apr; 350(6320):706-9. PubMed ID: 2023632
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of CD43 (leukosialin, sialophorin) by mononuclear phagocyte populations.
Howell DN; Ahuja V; Jones L; Blow O; Sanfilippo FP
J Leukoc Biol; 1994 Apr; 55(4):536-44. PubMed ID: 8145025
[TBL] [Abstract][Full Text] [Related]
12. CD43 (leukosialin, sialophorin) expression is differentially regulated by retinoic acids.
Babina M; Weber S; Henz BM
Eur J Immunol; 1997 May; 27(5):1147-51. PubMed ID: 9174604
[TBL] [Abstract][Full Text] [Related]
13. Protein sequence and gene structure for mouse leukosialin (CD43), a T lymphocyte mucin without introns in the coding sequence.
Cyster J; Somoza C; Killeen N; Williams AF
Eur J Immunol; 1990 Apr; 20(4):875-81. PubMed ID: 2347365
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of mononuclear cell activation by an anti-CD43 (sialophorin) agonistic antibody.
Silverman LB; Wong RC; Remold-O'Donnell E; Vercelli D; Sancho J; Terhorst C; Rosen F; Geha R; Chatila T
J Immunol; 1989 Jun; 142(12):4194-200. PubMed ID: 2542404
[TBL] [Abstract][Full Text] [Related]
15. Characterization of LK-1 monoclonal antibody against human sialophorin (CD43).
Koubek K
Folia Biol (Praha); 2000; 46(5):199-201. PubMed ID: 11055800
[No Abstract] [Full Text] [Related]
16. Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes.
Ardman B; Sikorski MA; Settles M; Staunton DE
J Exp Med; 1990 Oct; 172(4):1151-8. PubMed ID: 1976735
[TBL] [Abstract][Full Text] [Related]
17. Structural requirements for CD43 function.
Walker J; Green JM
J Immunol; 1999 Apr; 162(7):4109-14. PubMed ID: 10201935
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome.
Shelley CS; Remold-O'Donnell E; Davis AE; Bruns GA; Rosen FS; Carroll MC; Whitehead AS
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2819-23. PubMed ID: 2784859
[TBL] [Abstract][Full Text] [Related]
19. Human neutrophils release their major membrane sialoprotein, leukosialin (CD43), during cell activation.
Rieu P; Porteu F; Bessou G; Lesavre P; Halbwachs-Mecarelli L
Eur J Immunol; 1992 Nov; 22(11):3021-6. PubMed ID: 1358626
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of CD43 in RAEB and RAEB-T patients. Report of 3 cases.
Kyriakou DS; Alexandrakis M; Tzardi M; Stephanaki D; Eliopoulos GD
Am J Hematol; 2000 Jan; 63(1):20-7. PubMed ID: 10602163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
